Heather Cooper Ortner joins the International Myeloma Foundation as president & CEO

John Turchi named inaugural chair of Department of Biochemistry, Molecular Biology and Pharmacology at IU School of Medicine

John J. Turchi was named chair of the newly merged Department of Biochemistry, Molecular Biology, and Pharmacology at Indiana University School of Medicine.

October 03, 2025

Vol.51 No.36

Guest Editorial

Championing nurse wellbeing as a strategic priority

Working in a comprehensive cancer center requires emotional endurance, strong clinical judgment, and constant interprofessional collaboration, all of which rest on a foundation of personal wellness. For nurses, whose roles are inherently intensive, focusing on wellbeing is integral to their ability to provide safe, compassionate, and effective patient care.

September 26, 2025

Vol.51 No.35

By Kim Slusser

In Brief

Monica Bertagnolli nominated as the next president of National Academy of Medicine

Monica Bertagnolli, former director of NIH and NCI, is on the path to becoming the next president of the National Academy of Medicine.

September 26, 2025

Vol.51 No.35

In Brief

Nicholas Richardson joins Precision for Medicine as vice president of clinical development

Nicholas Richardson was named vice president of clinical development at Precision for Medicine, a company focused on biomarker-driven clinical research and development.

September 26, 2025

Vol.51 No.35

In Brief

Scott Eggener named chair of Urology at UCLA Health

Scott Eggener was named chair of the Department of Urology at the David Geffen School of Medicine at UCLA and executive medical director for urology for the UCLA Health system.

September 26, 2025

Vol.51 No.35

Clinical Roundup

Tecvayli + Darzalex Faspro achieves 100% MRD negativity in newly diagnosed MM, phase II study shows

An investigational immune-based induction regimen with Tecvayli (teclistamab-cqyv) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) demonstrated meaningful clinical efficacy in transplant-eligible patients with newly diagnosed multiple myeloma.

September 26, 2025

Vol.51 No.35

Heather Cooper Ortner joins the International Myeloma Foundation as president & CEO

YOU MAY BE INTERESTED IN

John Turchi named inaugural chair of Department of Biochemistry, Molecular Biology and Pharmacology at IU School of Medicine

Championing nurse wellbeing as a strategic priority

Monica Bertagnolli nominated as the next president of National Academy of Medicine

Nicholas Richardson joins Precision for Medicine as vice president of clinical development

Scott Eggener named chair of Urology at UCLA Health

Tecvayli + Darzalex Faspro achieves 100% MRD negativity in newly diagnosed MM, phase II study shows

Renew today!

Subscriber content

Never miss an issue!

Login